	2024	2025	2026	2027	2028
Revenue	3,384	3,680	4,084	4,689	5,123
Dividend	0.74	0.92	1.12	-	-
Dividend Yield (in %)	0.31 %	0.38 %	0.46 %	0.71 %	0.77 %
EPS	4.11	5.26	6.68	8.74	10.39
P/E Ratio	58.92	46.03	36.21	27.70	23.30
EBIT	603	732	887	1,162	1,333
EBITDA	942	1,090	1,254	1,481	1,633
Net Profit	166	259	368	-	610
Net Profit Adjusted	290	369	483	617	705
Pre-Tax Profit	429	586	793	1,019	1,175
Pre-Tax Profit Reported	343	523	686	928	1,041
EPS (Non-GAAP) ex. SOE	-	-	-	-	-
EPS (GAAP)	2.38	3.80	5.22	7.25	8.44
Gross Income	1,599	1,779	2,009	2,265	2,603
Cash Flow from Investing	-412	-390	-394	-511	-563
Cash Flow from Operations	790	831	967	1,220	1,356
Cash Flow from Financing	61	-460	-497	-439	-439
Cash Flow per Share	10.56	11.53	13.96	14.56	-
Free Cash Flow	343	408	530	703	778
Free Cash Flow per Share	4.33	5.33	7.35	15.99	19.44
Book Value per Share	57.20	59.19	65.38	52.03	62.16
Net Debt	4,005	3,777	3,453	3,211	2,836
Research & Development Exp.	177	183	193	215	240
Capital Expenditure	403	386	396	496	540
Selling, General & Admin. Exp.	885	907	951	1,090	1,170
Shareholder’s Equity	3,014	3,202	3,544	4,396	5,245
Total Assets	10,107	10,172	10,314	11,166	11,695

	Previous Quarter ending 09/30/24	Current Quarter ending 12/31/24	Next Quarter ending 03/31/25	Current Year ending 12/31/24	Next Year ending 12/31/25
Earnings Estimates
No. of Analysts	7	7	1	22	22
Average Estimate	0.897 EUR	1.267 EUR	1.340 EUR	4.122 EUR	5.283 EUR
Year Ago	0.126 EUR	0.123 EUR	0.536 EUR	2.999 EUR	-
Publish Date	10/17/2024	1/23/2025	4/17/2025	-	-
Revenue Estimates
No. of Analysts	7	7	1	22	22
Average Estimate	818 EUR	880 EUR	886 EUR	3,387 EUR	3,685 EUR
Year Ago	811 EUR	850 EUR	820 EUR	3,396 EUR	-
Publish Date	10/17/2024	1/23/2025	4/17/2025	-	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Sales	3,395.70	4,174.70	3,449.22	2,335.66	1,826.97	1,566.03	1,404.57
Change of sales in %	-18.66	21.03	47.68	27.84	16.66	11.50	8.02
Gross profit on sales	1,567.10	2,196.40	1,838.93	1,205.80	941.16	803.60	706.84
Gross profit on sales change in %	-28.65	19.44	52.51	28.12	17.12	13.69	11.88
Operating income	544.60	1,188.20	953.87	526.99	365.25	297.76	224.22
Operating income change in %	-54.17	24.57	81.00	44.28	22.67	32.80	4.98
Income before tax	392.40	1,181.70	668.42	446.68	303.18	270.70	198.59
Income before tax change in %	-66.79	76.79	49.64	47.33	12.00	36.31	-2.70
Income after tax	205.20	678.10	318.89	226.27	156.75	141.34	114.73
Income after tax change in %	-69.74	112.65	40.93	44.36	10.90	23.20	11.46

Balance Sheet in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Total liabilities	7,023.90	4,336.80	3,999.48	3,321.51	1,784.60	1,570.91	1,505.69
Long-term liabilities per share	83.23	37.03	35.84	35.82	16.42	15.94	16.26
Equity	2,757.40	2,658.90	1,720.20	1,402.21	1,081.21	973.39	806.56
Equity change in %	3.89	57.88	20.30	29.27	9.43	19.87	6.58
Balance sheet total	9,781.30	6,995.70	5,719.68	4,723.72	2,865.81	2,544.29	2,312.24
Balance sheet total change in %	39.82	22.31	21.08	64.83	12.64	10.04	30.86

Key Data in EUR

	2023	2022	2021	2020	2019	2018	2017
Sales per share	49.63	61.02	50.42	34.15	26.71	22.90	20.54
P/E ratio (year end quote, basic EPS)	111.09	37.27	127.70	103.85	83.25	52.69	47.35
P/E ratio (year end quote, diluted EPS)	111.09	37.27	127.70	103.85	83.25	52.69	47.35
P/E ratio (year end quote)	111.09	37.27	127.70	103.85	83.25	52.69	47.35
Dividend yield in %	0.22	0.39	0.21	0.21	0.19	0.57	0.64
Equity ratio in %	28.19	38.01	30.08	29.68	37.73	38.26	34.88
Debt ratio in %	71.81	61.99	69.92	70.32	62.27	61.74	65.12

Sartorius vz. Dividend Calendar

Date	Name	Dividend	*yield	Currency
2023	Sartorius AG Vz.	0.74	0.22	EUR
2022	Sartorius AG Vz.	1.44	0.39	EUR
2021	Sartorius AG Vz.	1.26	0.21	EUR
2020	Sartorius AG Vz.	0.71	0.21	EUR
2019	Sartorius AG Vz.	0.36	0.19	EUR
2018	Sartorius AG Vz.	0.62	0.57	EUR
2017	Sartorius AG Vz.	0.51	0.64	EUR
2016	Sartorius AG Vz.	0.46	0.65	EUR
2015	Sartorius AG Vz.	0.38	0.63	EUR
2014	Sartorius AG Vz.	0.27	1.07	EUR
2013	Sartorius AG Vz.	0.26	1.18	EUR
2012	Sartorius AG Vz.	0.24	1.43	EUR
2011	Sartorius AG Vz.	0.21	2.31	EUR
2010	Sartorius AG Vz.	0.16	2.26	EUR
2009	Sartorius AG Vz.	0.11	2.64	EUR
2008	Sartorius AG Vz.	0.11	5.15	EUR
2007	Sartorius AG Vz.	0.17	2.52	EUR
2006	Sartorius AG Vz.	0.16	1.94	EUR
2005	Sartorius AG Vz.	0.13	2.54	EUR
2004	Sartorius AG Vz.	0.11	2.76	EUR
2003	Sartorius AG Vz.	0.07	3.94	EUR
2002	Sartorius AG Vz.	0.07	7.03	EUR
2001	Sartorius AG Vz.	0.07	3.71	EUR
2000	Sartorius AG Vz.	0.07	3.02	EUR

*Yield of the Respective Date

Sartorius vz. Calendar

Event	Estimate	Info	Date
Earnings Report	0.897 EUR	Q3 2024 Earnings Release	10/17/2024
Earnings Report	1.267 EUR	Q4 2024 Earnings Release	01/23/2025
Earnings Report	1.340 EUR	Q1 2025 Earnings Release	04/17/2025
Earnings Report	1.420 EUR	Q2 2025 Earnings Release	07/18/2025
Earnings Report	1.420 EUR	Q3 2025 Earnings Release	10/15/2025

Sartorius vz. Past Events

Event	Actual EPS	Info	Date
Earnings Report	0.346 EUR	Q2 2024 Earnings Release	07/18/2024

Sartorius vz. Profile

Sartorius AG engages in the provision of solutions for biopharmaceutical research. It operates through following divisions: Bioprocess Solutions (BPS), and Lab Products and Service (LPS). The Bioprocess Solutions division focuses on single-use solutions, helps customers manufacture biotech medications and vaccines safely and efficiently. The Lab Products and services division serves the needs of laboratories performing research and quality control at pharma and biopharma companies and those of academic research institutes. The company was founded by Florence Sartorius, Sr. in 1870 and is headquartered in Goettingen, Germany.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Sartorius vz. Shareholder

Owner	in %
Freefloat	65.71
Bio-Rad Laboratories, Inc.	25.61
Sartorius AG	8.68
Vanguard International Growth Fund	3.70
T Rowe Price Growth Stock Fund	1.87
T Rowe Price New Horizons Fund	1.74
Franklin Growth Fund	1.27
BNP Paribas Aqua	0.97

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Sartorius vz. Management

Name	Job
Lothar Kappich	Chairman-Supervisory Board
Joachim Kreuzburg	Chief Executive Officer
Florian Funck	Chief Financial Officer
René Fáber	Head-Bioprocess Solutions Division
Alexandra Gatzemeyer	Head-Lab Products & Services Division
Volker Niebel	Head-Production, Procurement & Business Operations
Oscar-Werner Reif	Head-Research & Development
Annette Becker	Member-Supervisory Board
Daniela Favoccia	Member-Supervisory Board
David Raymond Ebsworth	Member-Supervisory Board
Dietmar Müller	Member-Supervisory Board
Frank Riemensperger	Member-Supervisory Board
Hermann Jens Ritzau	Member-Supervisory Board
Ilke Hildegard Panzer	Member-Supervisory Board
Klaus Rüdiger Trützschler	Member-Supervisory Board
Sabrina Wirth	Member-Supervisory Board
Petra Kirchhoff	Member-Supervisory Board & Head-IR
Manfred Zaffke	Vice Chairman-Supervisory Board